Recomienda este artículo a tus amigos:
The Path from Biomarker Discovery to Regulatory Qualification Federico Goodsaid
Precio
$ 77,99
sin IVA
Pedido desde almacén remoto
Entrega prevista 16 de jun. - 3 de jul.
Nuestros clientes opinan:
Añadir a tu lista de deseos de iMusic
The Path from Biomarker Discovery to Regulatory Qualification
Federico Goodsaid
Focuses on biomarker qualification, its history and regulatory settings in both the US and abroad. This book provides a look at the next step to developing biomarkers for clinical use and covers overall concepts, challenges, strategies and solutions based on the experiences of regulatory authorities and scientists.
206 pages, Illustrated
| Medios de comunicación | Libros Paperback Book (Libro con tapa blanda y lomo encolado) |
| Publicado | 16 de julio de 2014 |
| Fecha de lanzamiento original | 2013 |
| ISBN13 | 9780123914965 |
| Editores | Elsevier Science Publishing Co Inc |
| Páginas | 206 |
| Dimensiones | 192 × 235 × 10 mm · 408 g |
| Lengua | Inglés |
| Editor | Goodsaid, Federico (PhD, Vice President, Strategic Regulatory Intelligence, Vertex Pharmaceuticals, Cambridge, MA) |
| Editor | Mattes, William B. (PhD, DABT, Senior Director of COPD Biomarkers Qualification Consortium, COPD Foundation and Founder and Principal, PharmPoint Consulting) |
